Moderna
This role in Moderna’s Product Characterization group supports the advancement of the mRNA pipeline and commercial products by coordinating RNA characterization and comparability studies. The position interfaces closely with cross-functional analytical and process development teams and contributes to internal/external scientific communications and documentation supporting product development.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2010
Moderna is a biotechnology company that is pioneering the use of mRNA technology to develop transformative medicines and vaccines. It gained global prominence for its COVID-19 vaccine, which showcased the potential of mRNA in rapidly addressing public health emergencies. The company is focused on creating innovative therapies to treat a range of diseases, advancing its product pipeline, and exploring new career opportunities in the biotech field. With a commitment to changing the landscape of medicine, Moderna is at the forefront of scientific research and development.
Moderna | History, Innovation, Challenges, & Facts | Britannica Money
5 days ago
An Erratic FDA Is a Threat to Innovation
5 hours ago
Moderna, Inc. $MRNA Position Increased by Theleme Partners LLP
2 hours ago
Moderna operates through several specialized therapeutic “pillars”:
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Moderna.
6 hours ago
Scientist II – mRNA Platform Development
AbbVie
Associate Scientist/Scientist, mRNA Process Development
ASTARPRD
Senior Research Associate/Associate Scientist, Biochemistry
Flagship Pioneering, Inc.
Post Doctoral Scholar
The Ohio State University
Advisor - Biophysical/Analytical Scientist, Molecular Insights
Eli Lilly and Company
Scientist II – mRNA Platform Development
AbbVie